Ironwood sinks, Mizuho cuts Linzess estimates

Ironwood Pharmaceuticals (IRWD -4.1%) slides in morning trading.

Mizuho cuts its price target on the shares to $16 from $23.

Linzess FY13 revenue estimates slashed to $117M from $147M.

The company presented yesterday at the Morgan Stanley Global Healthcare Conference. (webcast)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs